Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.
第一作者:
Joy N,Tsai
第一单位:
Endocrine Unit, Massachusetts General Hospital, Boston, MA, USA.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);骨密度(Bone Density);骨密度保护剂(Bone Density Conservation Agents);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);中年人(Middle Aged);骨质疏松, 绝经后(Osteoporosis, Postmenopausal);放射摄影术(Radiography);桡骨(Radius);甲状旁腺激素肽(1-34)(Teriparatide);胫骨(Tibia)
DOI
10.1002/jbmr.2315
PMID
25043459
发布时间
2021-10-21
- 浏览58
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文